The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers
Clinical trial NCT05152017 · COMPLETED
Trial details
- NCT number
- NCT05152017
- Sponsor
- St. Petersburg Research Institute of Vaccines and Sera
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-16
- Primary completion
- 2020-01-22
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.